A comparison of HLH-related laboratory indicators was performed in the 17 HLH patients treated with this regimen before and 3 weeks after treatment, including triglycerides, fibrinogen, serum ferritin, sCD25 level, white blood cell count, neutrophil count, hemoglobin level, platelet count, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, total bilirubin level, and albumin. The gene discussed is GPT; the disease is hemophagocytic syndrome.